Very encouraging. Uplist to NASDAQ and AE37 divid
Post# of 36537
(Total Views: 146)
Posted On: 10/07/2019 9:14:56 AM
Very encouraging. Uplist to NASDAQ and AE37 dividend to be completed by the end of "this" month.
"In regards to Arizona, we've partnered with two large clinics, which represent around 65,000 patients. Most of the patients are Type I diabetics, so it's a good fit for ALTuCELL where we can do our clinical trial work," explained Moscato, adding that this step is necessary for the approval of the potential Type I Diabetes cure. "We're also putting in podiatry, ophthalmology, neurology, and pharmacy in these clinics."
Can this be accurate? Did Joe misspeak? Is this an error? Or, how did Arizona capture such a large population of people who were born with diabetes? "Most of the patients are Type I diabetics". Type II, maybe. Any clarification, doc.
"In regards to Arizona, we've partnered with two large clinics, which represent around 65,000 patients. Most of the patients are Type I diabetics, so it's a good fit for ALTuCELL where we can do our clinical trial work," explained Moscato, adding that this step is necessary for the approval of the potential Type I Diabetes cure. "We're also putting in podiatry, ophthalmology, neurology, and pharmacy in these clinics."
Can this be accurate? Did Joe misspeak? Is this an error? Or, how did Arizona capture such a large population of people who were born with diabetes? "Most of the patients are Type I diabetics". Type II, maybe. Any clarification, doc.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼